Navigation Links
Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
Date:6/19/2008

SYDNEY, Australia, June 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3 registration trial of Bronchitol for bronchiectasis via the Special Protocol Assessment process.

The SPA process allows for FDA evaluation of a clinical trial protocol intended to form the primary basis of an efficacy claim in support of a New Drug Application, and provides an agreement that the study design, including trial size, clinical endpoints and/or data analyses are acceptable to the FDA.

Pharmaxis previously agreed on the trial design with the European regulatory agency (EMEA). This trial will therefore form the basis of a marketing application in both the U.S. and Europe.

The phase 3 trial has been designed in collaboration with internationally renowned experts in the field of bronchiectasis and will be a randomized, placebo controlled, double-blind investigation of Bronchitol twice daily in approximately 350 adults with bronchiectasis. Participants will be treated for 52 weeks and the primary endpoints are reduction in frequency of exacerbations and improvement in quality of life. Secondary endpoints include time to first exacerbation and duration of exacerbation. Additional secondary endpoints are antibiotic use, sputum volume, exercise tolerance and lung function measurements. The trial includes health economic analysis and will be conducted in centers across Europe and the U.S.

This trial is the second Phase III study to be undertaken for Bronchitol in bronchiectasis and follows the completion of a successful shorter trial reported last year.

Pharmaxis CEO, Alan Robertson, said the company was pleased to have concluded its discussions with the FDA and the EMEA.

''We believe this phase 3 trial design will allow us to thoroughly demonstrate the clinical benefits of Bronchitol in a patient populat
'/>"/>

SOURCE Pharmaxis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmaxis Establishes Named Patient Program for Bronchitol
2. Pharmaxis Long-Term Safety Study of Bronchitol Completes
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
5. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
6. Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations
7. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
8. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
9. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
10. Specialized Genasense(R) Clinical Trials Featured at AACR Meeting
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... International Isotopes Inc. (OTCQB: INIS) (the "Company") ... 31, 2014.  The Company reports a 10% increase in ... cash flow for the year ended December 31, 2014. ... approximately $7.5 million compared to approximately $6.8 million in ... the exception of the radiological services segment, our three ...
(Date:4/1/2015)... , April 1, 2015 ... Report on Global Azithromycin Industry and 2015 ... Industry reports added to Pharmaceutical category in ... the report introduces Azithromycin basic information, including ... overview, policy analysis, and news analysis, etc. ...
(Date:4/1/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... its Glucose Clamp Study. The study will be performed ... San Antonio and University Health ... Ralph DeFronzo . The glucose clamp ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
(Date:4/1/2015)... Dallas, Texas (PRWEB) April 01, 2015 ... surgeon and Distinguished Teaching Professor of the Department ... joined with other doctors to review reports of blindness ... in cosmetic surgery . The group published their study, ... Plastic and Reconstructive Surgery journal. , "We began to ...
(Date:4/1/2015)... The 2015 Deep Market Research Report ... and in-depth study on the current state of ... a focus on the Chinese situation. , Major ... Pfizer, Lek Pharmaceuticals D.D., Dr Reddys Labs Ltd, ... Cadila Healthcare Limited, Sandoz Inc, Teva Pharms, Apotex ...
(Date:4/1/2015)... D.C. (PRWEB) April 01, 2015 It is ... solely for breakfast but now found wrapped around other foods, ... Bacon has been called meat candy, the gateway meat for ... a cultural icon, the North American Meat Institute (NAMI) has ... a video tour of a bacon processing plant ...
(Date:4/1/2015)... ScooterDirect.com is a one stop online store that provides ... using electric mobility scooters, power chairs and portable carts. ... they provide mobility scooters at an affordable price. They ... freedom. Scooterdirect.com is offering Pride Go Go Traveller Elite ... One of the team members quoted, “Pride Go Go ...
(Date:4/1/2015)... Phybridge Inc., a provider of ... its strategic partnership with SaskTel in a joint ... businesses of Saskatchewan. SaskTels’ Integrated Business Communications (IBC) ... offers users a hosted IP unified communications solution ... objective of IBC is to offer an end-to-end ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:ScooterDirect.com Offering Pride Go Go Traveller Elite 3 Wheel Scooter 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 3
... team effort, the best qualities of two drugs commonly prescribed ... medicines alone, according to a new study from UT Southwestern ... of the journal European Urology , compared treatments for ... years. The study, which included more than 4,800 men, is ...
... ... , ... March 2, 2010 -- Strategic Connections Inc., provider of the leading integrated communications and ... brand, including the "Strategic Connections" corporate name, a new logo, and a new url. ...
... ... the Adaptive Business Leaders Organization (ABL)’s 2010 “Leadership in Innovation” Award and make the ... in Newport Beach, California. , ... Santa Ana, CA (PRWEB) March 2, 2010 -- Debra Reisenthel, President and ...
... ... ... ... ...
... ... ... , ... , ...
... new study is providing insight into how estrogen fuels many ... new cancer-fighting drugs. Researchers found that estrogen inhibits a ... leads to uncontrolled growth of cancer cells and resistance to ... other centers reported the findings in the journal Cancer ...
Cached Medicine News:Health News:Combination therapy more effective for enlarged prostate 2Health News:Strategic Connections Inc. (SCI) Announces Market Expansion and New Brand 2Health News:Strategic Connections Inc. (SCI) Announces Market Expansion and New Brand 3Health News:Novasys Medical's Debra Reisenthel Named ABL's 2010 “Leadership in Innovation” Awardee 2Health News:Novasys Medical's Debra Reisenthel Named ABL's 2010 “Leadership in Innovation” Awardee 3Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 2Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 3Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 4Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 5Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 6Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 2Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 3Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 4Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 5
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
Medicine Products: